Maria Abreu on Muck Rack

Maria Abreu

Verified
As seen in: Octus, Forbes, Nature, Wiley Online Library, Correio Braziliense, MDPI, Taylor & Francis Online, Journal of Foot and Ankle Research, Forbes India, HCP Live, Forbes Middle East and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Maria

Contact Maria, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Maria Abreu, MD, on the DUET-UC Trial of Combination Therapy

|
By Maria Abreu Verified
| HMP Global Learning Network
My name is Maria Abreu. I am the executive director of the IBD Institute at Cedars-Sinai. And I have the privilege at the DDW of presenting at a late-breaking abstract on the results of DUET, a study that was conducted in ulcerative colitis patients using the combination of golimumab, which is an anti-TNF, with guselkumab, an anti-IL-23. And so what is the problem we're trying to address?
Open in Who Shared Issue with article?

DUET-UC Data Highlight Potential of Dual-Pathway Targeting in Refractory Ulcerative Colitis

|
By Maria Abreu Verified
| consultantlive.com
For patients with ulcerative colitis (UC) who have failed multiple lines of therapy, treatment options are limited and outcomes are often poor. A novel investigational approach simultaneously targeting 2 distinct inflammatory pathways with a single fixed-dose co-antibody may offer hope for changing that reality. Phase 2b data from the DUET-UC trial presented at Digestive Disease Week (DDW) 2026 in Chicago, IL, by Maria Abreu, MD, Executive Director of the F.
Open in Who Shared Issue with article?

An IL-17-DUOX2 axis controls gastrointestinal colonization by Candida albicans

|
By Pallavi Kakade, Juan Burgueno Verified, Shabnam Sircaik, Nicole O. Ponde, Iuliana V. Ene, Jiwoong Kim, Shen-Huan Liang, Rebecca Yunker, Ipsita Dey, Yasutada Akiba, Shipra Vaishnava, Jonathan D. Kaunitz, Andrew Koh, Sarah Gaffen, Maria Abreu Verified, Richard Bennett
| Nature Verified
Abstract Candida albicans is a ubiquitous fungus in the human gut yet there is little understanding as to how crosstalk between the fungus and the host regulates gut colonization. Here, we performed global expression profiling on germ-free mice colonized with C. albicans and found that Duox2 and Duoxa2, encoding a dual NADPH oxidase activity, were upregulated in the ileum and colon. Induction of Duox2/Duoxa2 was dependent on both candidalysin toxin secreted by C.
Open in Who Shared Issue with article?
See all 169 licensed articles (174 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified